Drug-Related Side Effects and Adverse Reactions
Showing 9951 - 9975 of >10,000
Acupuncture, Taste Disorders, Dysgeusia Trial in Essen, Mannheim (Hypoglossal acupuncture, Sham acupuncture, Dietary
Recruiting
- Acupuncture
- +4 more
- Hypoglossal acupuncture
- +2 more
-
Essen, NRW, Germany
- +2 more
Dec 5, 2022
Remimazolam Sedation for Nerve Blocks
Not yet recruiting
- Procedural Anxiety
- Procedural Pain
- Remimazolam 20 MG [Byfavo]
-
Salt Lake City, UtahUniversity of Utah
Jun 7, 2022
NSCLC Trial in United States (ALT-803, Nivolumab)
Active, not recruiting
- Non-small Cell Lung Cancer
- ALT-803
- Nivolumab
-
Weston, Florida
- +3 more
Dec 5, 2022
Parkinson Disease Trial in Farmington Hills, Leeuwarden (Lu AF28996)
Recruiting
- Parkinson Disease
- Lu AF28996
-
Farmington Hills, Michigan
- +1 more
Dec 5, 2022
Post-operative Delirium, Cognitive Dysfunction, Electroencephalography Trial in Istanbul (Bupivacaine-fentanyl, Saline)
Recruiting
- Post-operative Delirium
- +2 more
-
Istanbul, Fatih, TurkeyBezmialem Vakif University Hospital
Jan 15, 2023
Recurrent High Grade Glioma, Anaplastic Astrocytoma, Anaplastic Oligodendroglioma Trial (PCI 24781, Temozolomide)
Not yet recruiting
- Recurrent High Grade Glioma
- +4 more
- PCI 24781
- Temozolomide
- (no location specified)
Jan 24, 2023
Type 2 Diabetes Trial in Exeter (Sitagliptin - DPP4i, Canagliflozin - SGLT2i, Pioglitazone - TZD)
Completed
- Type 2 Diabetes
- Sitagliptin - DPP4i
- +2 more
-
Exeter, United KingdomExeter Clinical Research Facility
Mar 30, 2021
Carcinoma, Squamous Cell, Head Neck Cancer Trial in Lexington (Cisplatin, XRT)
Recruiting
- Carcinoma, Squamous Cell
- Head and Neck Cancer
- Cisplatin
- XRT
-
Lexington, KentuckyUniversity of Kentucky
Nov 17, 2021
BRAF V600E Unresectable or Metastatic Melanoma, BRAF V600E Metastatic NSCLC, Melanoma Trial in Guangzhou (Encorafenib)
Completed
- BRAF V600E Unresectable or Metastatic Melanoma
- +2 more
-
Guangzhou, Guangdong, ChinaSun Yat-sen University Cancer Center
Jun 9, 2022
Magnesium Sulfate, Postoperative Pain, Opioid Use Trial in São Paulo (Remifentanil group, Magnesium sulfate group)
Recruiting
- Magnesium Sulfate
- +2 more
- Remifentanil group
- Magnesium sulfate group
-
São Paulo, BrazilHospital das Clínicas - Faculdade de Medicina da Universidade de
Mar 2, 2022
Kidney Cancer Trial in Houston (Pazopanib, Temsirolimus, Quality of Life Assessment)
Completed
- Kidney Cancer
- Pazopanib
- +3 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Aug 24, 2021
Critical Lower Limb Ischemia, Peripheral Artery Disease Trial in Singapore (SELUTION Sirolimus DCB)
Active, not recruiting
- Critical Lower Limb Ischemia
- Peripheral Artery Disease
- SELUTION Sirolimus DCB
-
Singapore, SingaporeSingapore General Hospital
May 24, 2022
Peripheral Arterial Disease Trial in Germany, New Zealand, Switzerland (Temporary Spur Stent System)
Active, not recruiting
- Peripheral Arterial Disease
- Temporary Spur Stent System
-
Arnsberg, Germany
- +5 more
May 3, 2022
Cirrhosis Trial in Washington, San Juan (Defined Green Tea Catechin Extract, Laboratory Biomarker Analysis, Pharmacological
Active, not recruiting
- Cirrhosis
- Defined Green Tea Catechin Extract
- +3 more
-
Washington, District of Columbia
- +1 more
Jan 24, 2023
Treatment Compliance Trial in Karachi (to evaluate the safety and efficacy of Ansa for the treatment of UTi and control of Ecoli
Recruiting
- Treatment Compliance
- to evaluate the safety and efficacy of Ansa for the treatment of UTi and control of Ecoli infection
-
Karachi, Sindg, Pakistan
- +1 more
Oct 6, 2022
Rendu Osler Disease, Telangiectasia, Hereditary Hemorrhagic Trial (Bevacizumab)
Completed
- Rendu Osler Disease
- Telangiectasia, Hereditary Hemorrhagic
- (no location specified)
Oct 14, 2021
Palmoplantar Pustulosis (PPP) Trial in Japan (Risankizumab, Placebo)
Active, not recruiting
- Palmoplantar Pustulosis (PPP)
- Risankizumab
- Placebo
-
Ichinomiya-shi, Aichi, Japan
- +38 more
Mar 1, 2022
An Observational Study on Sarilumab-exposed Pregnancies
Recruiting
- Rheumatoid Arthritis -Exposure During Pregnancy
- Sarilumab SAR153191 (REGN88)
-
New York, New York
- +1 more
Jul 5, 2022
Obesity, Adolescent, Eating, Healthy Trial in Bilbao (Values alignment wise intervention, Educational traditional intervention)
Recruiting
- Obesity, Adolescent
- Eating, Healthy
- Values alignment wise intervention
- Educational traditional intervention
-
Bilbao, Vizcaya, SpainUniversity of Deusto
May 9, 2023